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One of the most important drawbacks of nanomedicine is related to the unwanted rapid diﬀusion of drugs
loaded within nanocarriers towards the external biological environment, according to the high clearance of
body ﬂuids. Therefore, colloids can carry only a small amount of their initial content in the target district,
limiting their pharmacological activity and then the therapy. To overcome this limitation, we synthesized
double conjugated nanogels: the ﬁrst click strategy (1,3 Huisgen cycloaddition) guarantees the
traceability of nanogels while the second one (disulﬁde bond) links drug molecules to polymeric chains.
In this study, we proposed the above-mentioned double strategy and we validated the synthesized
colloids and the selective release kinetics in microglia cells, dramatically involved in several diseases of
the central nervous system. Cleavable linked drugs prove to be a promising tool for the selective
administration of pharmacological compounds in microglia cells and potentially in many others
counteracting some relevant events.
Introduction
Recent advances in polymer science have provided many
innovations, underlining an increasing importance of poly-
meric nanocarriers as promising drug delivery tools.1–3 Indeed,
thanks to their exibility in terms of size, hydrophilic/lipophilic
characteristics and surface functionalization, they oﬀer relevant
advantages in drug delivery by targeting molecules in specic
cells and controlling drug release over time.4–7 In particular, one
of the greatest advantages of nanocarriers resides in the fact
that they can overcome some of the major limitations of
conventional delivery systems, like drawbacks of both under-
and over-dosing maintaining drug levels within a desired range
for a long period.8–10 Moreover, several studies showed the
intrinsic capacity of specic cells to internalize foreign nano-
bodies, which can be exploited for targeting drug delivery using
nanodevices.11,12 In order to improve the selectivity of nano-
carriers, specic targeting agents have been designed in recent
years.13–15 These state-of-the-art systems are able to transport the
loaded compounds specically to the target cells and release their
payload once there, following controlled or sustained kinetics.16–18
This approach, rstly used in cancer treatment, has now been
extended to several other districts and diseases.19–22 Among them,
in the last years a lot of attention was dedicated to nanosystems
able to selectively deliver drugs in the damaged central nervous
system using the high phagocytic activity of microglia.23,24
Along these lines, Papa and coworkers developed, for
example, poly-3-caprolactone based nanoparticles able to eﬃ-
ciently modulate resident microglial cells reducing their pro-
inammatory response, maintaining a pro-regenerative milieu
and ameliorating the behavioral outcome in mice up to 63 days
post spinal cord injury.25 In addition, this novel pharmacolog-
ical delivery by nanocarriers presents important improvements,
namely a selective drug delivery and a maximized pharmaco-
logical activity (anti-inammatory eﬀect) compared to other
administration routes such as direct parenchymal or intraper-
itoneal injection.
Cerqueira and coworkers proved that the intracellular
internalization of high concentration of methylprednisolone-
loaded CMCht/PAMAM dendrimer nanoparticles modulates
the metabolic activity of microglia cells in vitro and in vivo.26
These strategies promised to be very eﬃcient, but the main
limitation resides in the fact that the drug loaded could be
released during the transition to the target and the quantity of
drug that can be delivered in the site is generally very low.27–29
To overcome these drawbacks, a promising strategy is rep-
resented by the use of cleavable bonds between polymer and
aDipartimento di Chimica, Materiali e Ingegneria Chimica “Giulio Natta”, Politecnico
di Milano, via Mancinelli 7, 20131 Milan, Italy. E-mail: alessandro.sacchetti@polimi.
it; lippo.rossi@polimi.it; Fax: +39 0223993180; Tel: +39 0223993017; +39
0223993145
bDipartimento di Neuroscienze, IRCCS Istituto di Ricerche Farmacologiche “Mario
Negri”, via La Masa 19, 20156 Milan, Italy
cDipartimento di Ambiente e Salute, IRCCS Istituto di Ricerche Farmacologiche “Mario
Negri”, via La Masa 19, 20156 Milan, Italy
† Electronic supplementary information (ESI) available. See DOI:
10.1039/c7ra04584k
‡ These authors share senior authorship.
Cite this: RSC Adv., 2017, 7, 30345
Received 24th April 2017
Accepted 7th June 2017
DOI: 10.1039/c7ra04584k
rsc.li/rsc-advances
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 30345–30356 | 30345
RSC Advances
PAPER
Op
en
 A
cc
ess
 A
rti
cle
. P
ub
lis
he
d o
n 1
2 J
un
e 2
01
7. 
Do
wn
loa
de
d o
n 1
2/0
6/2
01
7 1
7:0
7:5
8. 
 T
his
 ar
tic
le 
is 
lic
en
sed
 un
de
r a
 C
rea
tiv
e C
om
mo
ns
 A
ttr
ibu
tio
n-N
on
Co
mm
erc
ial
 3.
0 U
np
ort
ed
 L
ice
nc
e. View Article Online
View Journal  | View Issue
drug molecules.30–32 Following this strategy, drug release is not
driven by Fickian diﬀusion but it is delayed by the stability of
the bond between drugs and polymer: the higher the stability,
the slower the release rates.33,34 The most common strategy in
order to functionalize polymers with drugs is represented by
polymer post-polymerization modication also known as click
strategies.30,35,36 Indeed, the presence of functional groups in
polymerization reaction may completely prevent polymeriza-
tion, modify polymer properties (molecular weight, poly-
dispersity, crystallinity, etc.) or lead to side eﬀects.
In this work we decided to functionalize nanogels (NGs)
composed by polyethylene glycol (PEG) and polyethyleneimine
(PEI) interconnections with a commonly used mimetic drug
rhodamine B (RhB)37,38 (click 1) using disulde bond that can be
disrupted by glutathione present within cell cytosol.39,40 In order
to be traceable, the nanogels were also functionalized with Cy5
dye (click 2) using Huisgen 1,3-cycloaddition. The synthesis,
characterization and size of nanocarriers were evaluated
together with their ability to release mimetic drug within
microglia cells. This study represents a good proof of concept of
the possibility to optimize dye and drug-conjunctions to poly-
mers to guarantee traceability on one side and improve drug
delivery performances on the other.
Experimental
Materials
Polyethyleneimine linear (PEI, MW ¼ 2500 Da) was purchased
from Polysciences Inc. (Warrington, USA), whereas polyethylene
glycol 8000 (PEG, MW ¼ 8000 Da), rhodamine, Cy5 dye and all
other used chemicals were purchased from Sigma-Aldrich
(Sigma Aldrich Chemie GmbH, Deisenhofen, Germany). The
materials were used as received. Solvents were of analytical
grade. Rhodamine derivatives were stored at 4 "C in dark. Syn-
thetized products with Cy5 moiety were stored at #20 "C.
Characterization and analyses
The NMR experiments were carried out on a Bruker AC (400
MHz) spectrometer using chloroform (CDCl3) or deuterium
oxide (D2O) as solvent, and chemical shis were reported as
d values in parts per million with respect to TMS as internal
standard. Final sizes and z-potentials of nanogels were deter-
mined by dynamic light scattering (DLS) analysis using a Zeta-
sizer Nano ZS from Malvern Instruments and the reported data
are an average value of three measurements of the same sample,
dissolved in distilled water. Atomic force microscopy (AFM)
analysis was performed for the characterization of nanogel
latexes using a NT-MDT Solver Pro instrument operating in non-
contact mode with silicon tips. Samples were prepared by
dropping latexes onto silicon substrate and drying. AFM images
on 1 $ 1 mm2 areas were recorded for the preliminary
morphologic evaluation; 500 $ 500 nm2 image were then
cropped and height line prole performed for single gel. Surface
morphology was evaluated by attening of the images (rst
order) using NT-MDT soware.
Nanogel synthesis
Synthesis of amine modied rhodamine 1. The functionali-
zation of rhodamine B base with amine moiety was performed
referring to the method discussed by Alam and coworkers.41
Briey, rhodamine (1.2 g, 2.5 mmol) was dissolved in ethanol
(30 ml) and ethylenediamine (220 ml, 3.25 mmol) was added
dropwise at room temperature. The mixture was kept stirring,
heating to reux for 72 h, until colour change from violet to
orange occurred. The solvent was evaporated under reduce
pressure. Excess of diethyl ether (40 ml) was added and the
resulting precipitate was collected by vacuum ltration and
dried under vacuum to obtain the product as a powder (75%
yield). The modied rhodamine was veried by 1H-NMR anal-
ysis. 1H NMR (400 MHz, CDCl3): d 7.90 (m, J¼ 5.3 Hz, 1H), 7.48–
7.37 (m, 2H), 7.09 (m, J ¼ 4.6 Hz, 1H), 6.43 (d, J ¼ 8.7 Hz, 2H),
6.38 (d, 2H), 6.32–6.18 (dd, 2H), 3.33 (q, J ¼ 7.3 Hz, 8H), 3.18 (t,
J ¼ 6.6 Hz, 2H), 2.41 (t, J ¼ 6.6 Hz, 2H), 1.16 (t, J ¼ 7.0 Hz, 12H).
Found: C, 74.08; H, 7.83; N, 11.52. Calc. for C30H38N4O2: C,
74.04; H, 7.87; N, 11.51%.
Synthesis of 2-propynoxyethyldisulphanylethanol 2. Refer-
ring to the procedure of Li and coworkers,42 2-hydroxyethyl
disulde (10 g, 64 mmol) was dissolved in THF (100 ml); the
solution was cooled to 0 "C and then propargyl bromide 80% in
toluene (3.6 g, 32 mmol) and sodium hydride (1.15 g, 38 mmol)
were added. The system was stirred for 10 h at room tempera-
ture and, successively, 10 drops of distilled water were added to
stop the reaction. The mixture was ltered and the solvent was
removed under reduced pressure. The crude product was puri-
ed by column chromatography (hexane : ethyl acetate 9 : 1 v/v)
resulting in a pale-yellow oil (60% yield), which was character-
ized by NMR analysis. 1H NMR (400 MHz, CDCl3): d 4.20 (d, J ¼
2.0 Hz, 2H), 3.93–3.86 (t, 2H), 3.83–3.74 (t, 2H), 2.93 (t, J ¼
6.4 Hz, 2H), 2.89 (t, J ¼ 5.9 Hz, 2H), 2.47 (t, J ¼ 2.4 Hz, 1H),
2.04 (s, 1H).
Found: C, 43.68; H, 6.30. Calc. for C7H12O2S2: C, 43.72; H,
6.29.
Synthesis of alkyne modied rhodamine-disulde bridge 3.
Separately, 1,10-carbonyldiimidazole (CDI, 50 mg, 0.31 mmol)
was dissolved in CH2Cl2 (2 ml) and 2 (59.5 mg, 0.31 mmol) was
dissolved in other CH2Cl2 (2 ml). The latter was added dropwise
to the CDI solution, at 0 "C and the resulting mixture was stirred
for 4 h. Then, functionalized rhodamine 1 (150 mg, 0.31 mmol)
was added and the nal system was le stirring for 16 h at room
temperature. The desired product was recovered aer extraction
using HCl 1 M (3 $ 5 ml): the organic phase was dried over
anhydrous sodium sulfate, ltrated and concentrated under
vacuum to get a purple solid (85% yield). 1H NMR (400 MHz,
CDCl3): d 7.95–7.74 (m, 1H), 7.51–7.30 (m, 2H), 6.99 (m, J ¼ 5.8,
2.7 Hz, 1H), 4.19–4.06 (d, 2H), 3.83 (t, J ¼ 5.8 Hz, 2H), 3.77–3.68
(t, 2H), 3.31 (q, J¼ 7.3 Hz, 8H), 3.25 (t, J¼ 6.6 Hz, 2H), 2.90 (t, J¼
5.9 Hz, 2H), 2.39 (t, J ¼ 2.2 Hz, 1H), 1.16 (t, J ¼ 7.6, 6.9 Hz, 12H).
Found: C, 64.77; H, 6.89; N, 7.92. Calc. for C38H48N4O5S2: C,
64.74; H, 6.86; N, 7.95.
Synthesis of diepoxy PEG 4. Diepoxy-terminated PEG was
synthetized referring to the procedure discussed by Teodorescu
and coworkers.43Briey, PEG (2 g, 0.25mmol) and epichlorohydrin
30346 | RSC Adv., 2017, 7, 30345–30356 This journal is © The Royal Society of Chemistry 2017
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(587 ml, 7.50 mmol) were dissolved in toluene (12 ml) and then,
NaOH (300 mg, 7.50 mmol) was added as a powder to the stirred
solution. The reaction system was le stirring at 50 "C for 7 h,
cooled to room temperature and extracted with distilled water (2$
10 ml). NaCl was added to neutralize the aqueous solution, which
was then extracted with CH2Cl2 (4 $ 15 ml). The resulting organic
phase was dried over anhydrous sodium sulfate and concentrated
under reduced pressure.
The nal product was obtained as white solid dissolving the
residue in excess of diethyl ether and collecting the formed
precipitate by ltration under vacuum (97% yield). The epoxide
moiety linked to the polymeric chain was evaluated by 1H-NMR
analysis. 1H NMR (400 MHz, CDCl3) d: 3.57 (s, 720H), 3.12–3.04
(m, 2H), 2.72 (dd, J ¼ 5.1, 4.1 Hz, 2H), 2.54 (dd, J ¼ 5.0, 2.7 Hz,
2H).
Synthesis of PEG–OH–N3 5. Ring-opening reaction of the di-
epoxide functionalized PEG occurred as proposed by Zhang and
coworkers.44 Polymer 4 (800 mg, 0.11 mmol) was dissolved in
DMF (15 ml) and then sodium azide (130 mg, 2 mmol) and
ammonium chloride (216 mg, 4 mmol) were added to the
solution. The reaction system was stirred at 60 "C for 48 h. The
crude product was concentrated under reduced pressure and
then precipitated into diethyl ether. The obtained solid was
dissolved in CH2Cl2 and diethyl ether was added again to
precipitate the nal puried polymer (90% yield). 1H NMR (400
MHz, CDCl3) d: 3.58 (s, 720H), 3.28 (d, J ¼ 5.5 Hz, 4H).
Synthesis of activated PEG-rhodamine 6. The formation of
stable bond between modied PEG 5 and the complex 3
carrying the mimetic drug was obtained through copper-
catalyzed alkyne–azide cycloaddition (CuAAC). The polymer 5
(250 mg, 31.25 mmol) was dissolved in a solution of acetonitrile
(10 ml) and water (4 ml), whereas the compound 3 (44 mg, 62.5
mmol) was dissolved in acetonitrile (3 ml). Therefore, the poly-
mer solution was added dropwise to the other organic solution.
To this system, copper iodide (7 mg, 37.5 mmol) and sodium
ascorbate (7.5 mg, 37.5 mmol) were added. The reaction mixture
was allowed to stir at 50 "C for 48 h. Subsequently, it was cooled
to room temperature, concentrated under reduced pressure and
re-dissolved in distilled water. The purication of the product
was performed through dialysis (membrane Mw cutoﬀ ¼ 3.5
kDa) against distilled water (2 l). Dialysis occurred for two days,
with daily replacement of the aqueous media.
The resulting system was lyophilized, giving a purple solid.
This intermediate was labelled as compound 5-R. Finally, the
latter (30 mg, 4 mmol) was dissolved in acetonitrile (5 ml) and
CDI (0.97 mg, 6 mmol) was added. The reaction mixture was le
stirring at 40 "C for 70 h. Successively, the solvent was evapo-
rated under vacuum and the residue was precipitated into
diethyl ether. The formed solid was collected and dried by
vacuum ltration and characterized by NMR analysis and gel
permeation chromatography (ESI†).
Synthesis of PEI-Cy5 7. The synthesis of PEI bond to the dye
Cy5-azide required two steps: the rst one was the functionali-
zation of PEI with alkyne moieties and the second one was the
click reaction (CuAAC) between the polymer and the dye. PEI
was modied with triple bonds using propargyl bromide, as
described in our previous work,45 using a molar ratio
PEI : propargyl bromide 1 : 5. The formation of triazole using
click strategy was performed as follows: functionalized PEI
(10 mg, 4 mmol) was dissolved in distilled water (2 ml) and
a solution (200 ml, 0.4 mmol) of Cy5-azide in DMSO (2 mg ml#1)
was added to the system. Copper iodide (0.02 mg, 0.2 mmol) and
sodium ascorbate (0.02mg, 0.2 mmol) were added to themixture
and the latter was heated to 50 "C for 24 h, under stirring. Then,
the resulting system was dialyzed against distilled water (2 l),
using dialysis membrane with Mw cutoﬀ ¼ 500 Da, for 2 days,
with daily replacement of the aqueous media. The polymer was
collected aer lyophilization and 1H-NMR spectrum conrmed
the polymer functionalization.
Nanogel formation
Nanogels were performed referring to themodied emulsication-
evaporation method.46 Activated PEG-rhodamine 6 (28 mg, 2.88
mmol) was dissolved in CH2Cl2 (1 ml), whereas modied PEI-Cy5 7
(5 mg, 1.92 mmol) was added to distilled water (2 ml) until
complete dissolution.
The organic solution was added dropwise, under vigorous
stirring, to the aqueous one and the resulting system was
sonicated for 30 min. CH2Cl2 was evaporated and the mixture
le stirring for 17 h at room temperature. Formed nanogels
were puried by dialysis (membrane Mw cutoﬀ ¼ 3.5 kDa)
against distilled water (2 l) and lyophilized. They were charac-
terized by 1H-NMR and FT-IR spectra. Moreover, the diameter
and the shape of these nanostructures were evaluated by DLS
and AFM analyses.
Rhodamine release from nanogels
Drug release mechanism was investigated in two diﬀerent
release environments: the rst one was a phosphate buﬀer
saline solution (PBS) at pH 7.4, whereas the second one was
a glutathione (GSH) solution 5 mM. Obtained nanogels (5 mg)
were separately placed in excess of PBS and GSH solution (1 ml)
and stored at 37 "C. At dened interval of time, for each sample,
aliquots (3 $ 100 ml) of the released media were collected for
UV-vis measurements and substituted, respectively, with the
same volume of fresh PBS or GSH solution, in order to avoid
mass-transfer equilibrium with the surrounding release envi-
ronment. The released amount of mimetic drug was spectro-
photometrically measured at 570 nm and determined referring
to the standard calibration curve for amine-rhodamine 1 (ESI†).
The percentage of the released rhodamine was dened as the
ratio of the released absolute amount in the aqueous media to
the sum of the total amounts of the released and unreleased
mimetic drug. All these experiments were repeated 3 times and
the results were averaged.
Biological evaluation: cell-mediated drug release
Cell culture. Primary cultures of microglia were obtained
from the spinal cord of 13 day-old C57 BL/6Nmouse embryos as
previously described.47 Briey, spinal cords were dissected,
exposed to DNAse and trypsin and centrifuged through a BSA
cushion.
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 30345–30356 | 30347
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Cells obtained at this step were a mixed neuron/glia pop-
ulation and underwent centrifugation through a 6% iodixanol
(OptiPrep™) cushion to separate large neurons from glial cells.
The glial fraction was plated at a density of 25 000 cells per cm2
into 75 cm2 asks, previously pre-coated with poly-L-lysine.
Isolated microglia were obtained from asks containing
conuent mixed glial cultures aer overnight shaking at
275 rpm in incubators. The supernatants (containingmicroglia)
were collected and seeded at a density of 40 000 cells per cm2
into 24-well plates. NGs (0.05% weight/volume) were then
added to cell cultures up to 3 days.
Cytocompatibility. Aer 5 days of culturing, the cytotoxicity
of nanogels was evaluated by performing anMTS assay and level
of lactate dehydrogenase (LDH) release.48 The absorbance was
measured at 570 and 490 nm respectively, and the results were
compared with that of the control wells to determine relative
cell viability.
Microscope analysis: in vitro drug release. Fluorescence was
acquired at 10$ objective magnication (BX61, Olympus,
Japan) using a 16 bit high-resolution camera (Fluoview II,
Olympus, Japan) and an appropriate lter cube avoiding cross
talk of signals between diﬀerent uorochromes. Fluorescent
staining was quantied using the signal segmentation plugin of
ImageJ soware (http://www.rsbweb.nih.gov).
Statistical analysis. Where applicable, experimental data
were analyzed using Analysis of Variance (ANOVA) and Tukey
post-test. Statistical signicance was set to p value < 0.05.
Results are presented as mean value % standard deviation.
Results and discussion
Chemical characterization
PEG functionalization: rhodamine-disulde linkage. The
design of sensitive systems to biological stimuli appears as
a leading strategy to achieve controlled drug release dependent
on intracellular trigger mechanism. Indeed, the synthesis of
covalent bonds readily broken by dened biomolecules allows to
obtain a drug release that is not only dependent on the diﬀusion
coeﬃcient of the molecules through the polymeric matrix, but it
is inuenced by the characteristics of chemical binding between
the loaded drug and the polymeric network. This permits to
interfere into the drug release kinetics, without any external
complementary assistants and allowing free drug level within
a desired range over a long period. PEG functionalization with
a S–S linker carrying rhodamine is proposed as a technique to
achieve this aim. The disulde bond has found increasing
attention for the application on controlled drug delivery systems,
due to its high redox sensibility.49 It could be broken by thiol
Fig. 1 Steps of synthesis of disulﬁde derivative grafting on one side the terminal alkyne group (A) and on the other side rhodamine (B).
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compounds, such as cysteine and glutathione, commonly
present in human cells.50,51 The polymer modication was per-
formed through the synthesis of a system where the only cleav-
able bond was S–S bridge. In detail, one terminal –OH group of
the disulde-functional reagent was chemically modied with
alkyne moiety (Fig. 1A), whereas its other hydroxyl group reacted
with amine modied rhodamine (Fig. 1B).
In this way, the mimetic drug was linked to the S–S bridge
structure, which in turn was graed to a triple bond, needed for
the formation of a stable and non-cleavable linkage with PEG.
Obtaining the compound 3 necessarily involved the purication
of the compound 2 (NMR spectrum visible in Fig. S1†) by chro-
matographic technique in order to separate the correct product
carrying only one alkyne functionality and one –OH group.
Indeed, the hydroxyl groups of 2-hydroxyethyl disulde
showed the same reactivity, due to its molecular symmetry, and
the foresight to use a molar ratio disulde: propargyl between
the reagents equal to 1 : 1, in order to potentially involve only
Fig. 2 Synthesis of PEG with both terminal epoxide moieties.
Fig. 3 Functionalization of PEG with azide groups. The reaction allowed restoring the hydroxyl groups of the polymer.
Fig. 4 Click reaction between modiﬁed PEG–OH–N3 5 and rhodamine derivative 3.
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 30345–30356 | 30349
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one –OH group of each molecule in the reaction with the alkyne
derivative, was not enough to produce the desired product
because the formation of a mixture of mono-, bis-, or no func-
tionalized system was obtained. The integral values of the
characteristic signals of 2 in its 1H-NMR spectrum, conrmed
the collection of the mono-functionalized product (ESI†). The
introduction of triple bond was justied by the need to gra the
sensitive drug-disulde linker system to the polymeric chain
using copper-catalyzed azide alkyne cycloaddition (CuAAC). The
formed triazole ring possesses a number of desirable features
reported in the medicinal chemistry and, in particular, is stable
under standard physiological conditions, which suits well for
gene and drug delivery system. The use of click chemistry
required the functionalization of PEG with azide moiety, that
was performed in two steps. The rst one, as illustrated in
Fig. 2, involved the preparation of the polymer with epoxide end
groups, through reaction with epichlorohydrin. PEG function-
alization was veried by 1H-NMR analysis (Fig. S2†), that
showed the specic peaks of the epoxy ring at 3.12 ppm,
2.72 ppm and 2.54 ppm, and then estimated according to the
literature procedure:43 resulting polymer was characterized by
all hydroxyl terminal groups substituted by epoxide groups.
The second step, reported in Fig. 3, consisted in the ring-
opening reaction of di-epoxide PEG using sodium azide and
ammonium chloride as a coordinating salt;52 in this case, 1H-
NMR analysis revealed new signals related to the methylene
group adjacent to azide group at 3.28 ppm, while the epoxide
proton resonances disappeared (Fig. S3†). In this way, we
introduced –N3 moiety and restored –OH groups at both PEG
sides. The importance of the presence of hydroxyl groups was
Fig. 5 (A) FT-IR spectrum of compound 3, (B) FT-IR spectrum of functionalized PEG 5-R, (C) FT-IR of functionalize PEI 7, (D) FT-IR spectrum of
synthetized nanogels.
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related to their chemical modication with imidazole, essential
for PEG-PEI nanogel synthesis.
Finally, the click reaction between PEG–OH–N3, 5, and
disulde bridge with rhodamine on one side and alkyne group
on the other end, 3, was carried out with copper iodide as the
catalyst, sodium ascorbate as reducing agent and a mixture of
acetonitrile-water as the solvent (Fig. 4). According to the pres-
ence of two azide groups for each PEG chain, the used molar
ratio between 5 and 3 was equal to 1 : 2, in order to ensure
quantitatively the reaction. The disulde functionalized PEG
was puried by dialysis against distilled water to remove
unreacted chemicals and salts. The formation of triazole was
conrmed by its characteristic signal in 1H-NMR spectrum
(Fig. S4†). Moreover the GPC chromatogram visible in Fig. S6†
reveals the presence of functonalized polymer.
Fig. 5B shows the FT-IR spectrum of the modied PEG,
where the characteristic signals of triazole can be recognized at
1471 cm#1, 1448 cm#1, 1440 cm#1, as outlined in the gure. The
broad peak around 3420 cm#1 corresponding to the stretching
vibration of terminal –OH bonds, whereas the signals at 2880
cm#1 and at 1114 cm#1 are respectively due to the C–H and
C–O–C stretch of the polymer chain. Other characteristic PEG
signals, related to the C–H bending, are found in the
wavenumbers range around 1470 O 800 cm#1. In addition, in
the range 1750 O 700 cm#1 peaks related to rhodamine are
detectable according to the signals of the FT-IR spectrum of
compound 3 (Fig. 5A): this conrms that PEG is linked in
a stable manner to the modied mimetic drug and it is still
reected in the absence of the alkyne signal at 3300 cm#1,
which is, otherwise, clearly visible in the spectrum of compound
3. The latter also shows the characteristic stretching vibration of
C]O at 1715 cm#1, represented also in the spectrum of the
functionalized PEG.
PEI functionalization: click with Cy5. PEI was modied
using propargyl bromide in a feed ratio of 1 : 5 and the excess
amount of the alkyne groups in comparison to polymer was
used to ensure the reaction conversion. The percentage of
linked propargyl moiety was evaluated referring to 1H-NMR
spectrum: as illustrated in our previous work,45 the ratio
among the integral value of the signal at 3.55 ppm, related to
monomer propargyl derivative, and the peaks corresponding to
PEI-block in the range 3.50–2.90 ppm, suggested that the
functionalization degree of the polymer was 10%. The signal
corresponding to the H of alkyne was covered by the peak of the
polymer chains. The resulting product reacted with Cy5-N3
using click strategy CuAAC (Fig. 6), in a similar manner as
Fig. 6 Synthesis procedure of PEI linked through click strategy to dye Cy5.
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described in the previous section about the formation of tri-
azole between PEG and disulde derivatives.
PEI linked to Cy5 was collected aer purication by dialysis
to remove unreacted chemicals and avoid the separation of
product as PEI complexes with copper. 1H-NMR spectrum
showed the characteristic signal of triazole at 8.10 ppm and FT-
IR spectrum sets out the corresponding peaks around 1470
cm#1. Fig. 5C also shows PEI peculiar signals: at 3240 cm#1 due
to N–H stretching, in the range 2945 O 2820 cm#1 of C–H
stretching, at 1643 cm#1 representative of N–H bending, at 1463
cm#1 related to PEI C–H bending and in the wavenumber range
1400 O 900 cm#1 the peaks are due to C–N stretching.
According to the emission/absorbance of Cy5 dye,53 its corre-
sponding signal is reported around 630 cm#1. PEI functionali-
zation could occur at higher percentage of linked alkyne group
and then of graed Cy5, just increasing the amount of propargyl
bromide involved in the corresponding reaction. However, our
study suggests that a dye functionalization degree of 10% is
satisfactory for ensuring the traceability of the nal nanogel
systems within cellular media. In addition, lower chemical
modication of PEI chain allows maintaining its peculiar
properties without any potential alterations, in particular the
availability of amine moieties for the successive nanogel
synthesis. Cy5 was chosen due to its functional detection in
biological application; cyanine derivatives are characterized by
the fact that absorbance and uorescence wavelength can be
controlled by polymethine bridge length: longer cyanines
possess higher absorbance and emission wavelengths up to
near infrared region. Cy5-N3 is uorescent in the red region
(&650 excitation, 670 nm emission) and its signal is detectable
where many charge-coupled devices detectors have better
sensitivity, and biological compounds have lower background.
In this way, it is possible to mark the used polymer and also
investigate its fate in the in vitro experiments.
Nanogel composition
Synthesis of biocompatible PEG-PEI nanogels was achieved by
coupling of modied PEG 6 and PEI 7 using a modied emul-
sication–evaporation method.46 According to this procedure,
the solution of activated PEG (graing the disulde bridge-
rhodamine system) in dichloromethane was emulsied in the
aqueous solution of PEI (graing Cy5) by sonication. Aer the
completion of the cross-linking reaction, the organic solvent
was removed under vacuum, and nanogel was allowed to form
in the aqueous medium (Fig. 7). The growing stage completed
the rearrangement of linked polymers, according to the chain
entanglements in the forming nanogel networks. The resulting
suspension was subjected to purication via dialysis to remove
by-products and unreacted polymers.
The eﬀective synthesis of nanogels was veried by 1H-NMR
data, where the signals at 4.12 ppm and at 3.38 ppm corre-
spond, respectively, to the two methylene protons of PEG and
PEI monomer forming the carbamate bond (Fig. S5†). This
conrmed the cross-linking between the two polymer chains.
The composition of this nanostructures was estimated in terms
of molar ratio between the polymers, considering the integral
values of the PEG (range 3.80–3.40 ppm) and PEI (range 2.85–
0.80 ppm) chains signals and it turned out to be PEG : PEI
1.5 : 1. FT-IR spectrum reported in Fig. 5D shows the distinctive
Fig. 7 Scheme of nanogel synthesis.
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signals of the polymers and their corresponding functionaliza-
tions according to the FT-IR spectra of modied PEG (Fig. 5B)
and PEI (Fig. 5C); in particular, the presence of signal at about
1710 cm#1 is representative of C]O stretching related to the
carbamate linkage.
Physical characterization
One of the most important issues in the eld of nanoscience is
the size eﬀect on the biodistribution, kinetic of release, and
cellular uptake of nanoparticles.54 Therefore, the investigation
of nanogel dimensions is necessary to design system able to be
internalized through active or passive uptake. Dynamic light
scattering (DLS) is a widely used technique for nanoparticle size
and z-potential determination in suspension. The measured
hydrodynamic diameter represents the dimension of the poly-
meric sample together with layer of surface-bound solvent.
Recorded DLS data provide nanogel average diameter equal to
462 nm (polydispersity index, PDI ¼ 0.066) and a surface charge
of +21.8 mV. The positive value of z-potential indicates that
nanogels are characterized by a positive surface charge, prob-
ably due to the ability of PEI, although alkyne functionalization,
to preserve part of its positive charge in the nal polymeric
network. Size distribution may be quantied by using atomic
force microscopy (AFM) analysis, obtaining additional infor-
mation about the morphology. In this case, the obtained size is
250 nm (data not shown). The size of the nanogels observed by
AFM was less than those measured using DLS.
This variation between AFM and DLS measurements is
justiable considering the diﬀerence in the sample processing:
in DLS, the slight increase in size is due to the nanogel swelling
behaviour in aqueous solution. This problem was not present
with hydrophobic polymeric nanoparticles synthesized by our
group and presented in previous work.55 In that case, the
complete accordance between AFM and DLS was due to the fact
that in that system swelling phenomenon was negligible.
Therefore, obtained results suggested that nanogels presented
particle diameter and surface charge within the range useful to
promote cellular internalization, according to the guideline in
the rational design of drug nanocarriers with maximized ther-
apeutic eﬃcacy.25
Drug release mechanism
The eﬃcacy of synthetized nanogels as selective drug delivery
systems was investigated performing the rhodamine release
experiments in two diﬀerent media, at 37 "C. The rst one was
GSH solution 5 mM, prepared in a pH 7.4 phosphate buﬀer and
representative of the average intracellular glutathione concen-
tration in human body;49 whereas, the second one was PBS
solution, chosen as a reference, in order to evaluate the poten-
tial GSH-responsive eﬀect of our nanosystems. The aim was the
evaluation of the interactions between a disulde bond and
a thiol compound: the rst one is slightly degradable under
physiological conditions but can be quickly cleaved in a highly
reductive environment within the cells, achieving controlled
intracellular rapid drug release. A schematic representation of
the rhodamine release mechanism that could occur within
cellular membrane is reported in Fig. 8: the S–S reduction could
Fig. 8 Scheme of rhodamine release within a cell, due to the reduc-
tion of S–S bond by thiol compound.
Fig. 9 Mechanism of rhodamine release from nanogel system in presence of GSH.
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be performed by GSH or cysteine cell component (both present
–SH group and interact in a similar manner).56,57
About thiol-sensing in biological samples, GSH has a leading
role because it is the most abundant thiol in cells.51,58 The
percentage of rhodamine released from the nanogels was dened
as the ratio between the release amount in the aqueous media
and the total amount linked to the polymeric network. The
spectrophotometrical evaluation of escaped rhodamine was
performed referring the calibration curve of the mimetic drug as
aminemodied rhodamine 1: the disulde cleavage in the redox-
responsive environment allowed the release of 1, as showed in
Fig. 9, without any other linked functionalizations (which,
otherwise, are needed to the synthesis of the nal sensitive
nanogels), that could distort the UV-vis measurements.
Fig. 10 shows the release proles in GSH (in black) and in
PBS (in blue) solutions. It is well visible that rhodamine release
is faster in media containing the thiol compound and it is
completed within 150 h. Release prole associated to the
physiological PBS media is prolonged for a much longer period,
underling that the key diﬀerence between the two release
mechanisms is related to the presence or absence of GSH. In
particular, it is evident that the synthetized nanogels are thiol-
sensitive and the disulde bridge plays a leading role in the
development of redox-responsive nanogels. In these systems,
the release of rhodamine occurred due to the selective reduc-
tion of S–S moiety caused by GSH that is the driving force
inuencing the release kinetic. In addition, considering that
used GSH concentration is representative of the thiol amount
Fig. 11 (A) Microglial cells show a prevalent colocalized signal of Cy5 and RhB in the cytosol after 24 h of exposure (a–c). A markedly diﬀused
signal of RhB is evident in the cytosol after 4 days from the NG internalization (d–f). Scale bar ¼ 50 mm. (B) Representative colocalization analysis
by Pearson's coeﬃcient shows a diﬀerent colocalization of NPs (Cy-5, green) with RhB (red) after 1 day and after 4 days. p value**¼ p < 0.001 (C)
Microglia viability after incubation with nanogels for 4 days. The columns represent the mean % SD.
Fig. 10 Release proﬁle of rhodamine delivered from nanogels in GSH
media (', black) and in PBS solution (', blue). The values are calculated
as a percentage with respect to the total mass loaded (mean value %
standard deviation is plotted).
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detectable within cells, produced nanostructures seemed to be
a promising tool to achieve a sensitive drug release caused only
by common intracellular compounds, without any other
external stimuli. In physiological environment without GSH,
released rhodamine occurred with lower delivery rate, main-
taining 70% of loaded mimetic drug still linked to the nanogel
network at 14 days. In this case, the release was not caused by
chemical interaction with GSH, but due to the progressive
degradation of the disulphide bond in physiological conditions,
considering its moderate instability towards the electrophilic
and nucleophilic nature of polar solvents.59
The obtained results allow to state that the design of
a disulde linker make it possible to release a drug within
intracellular environment due to the simple interactions with
cell components, whereas an extracellular media (such as a PBS
solution) decreases its susceptibility to reduction. In this way,
the developed nanostructures could be considered useful for
further investigations of intracellular drug release such as
hydrophilic analgesic and anti-inammatory drugs that are
characterized by carboxyl terminal group, steric hindrance and
resemblance in a similar manner to rhodamine structure
(examples are: fenoprofen, diunisal, mefenamic acid or
ketorolac).
In vitro cell-selective drug release
To further understand whether polymeric NGs were able to
deliver linked compounds into the cytosol of microglia we
observed release prole of RhB (as drug mimetic) from Cy5
decorated nanogels.
The colocalization of single uorescent Cy5-positive NGs
(pseudocolor green) loaded with RhB (pseudocolor red) showed
that the mimetic drug was eﬃciently encapsulated (Fig. 11A). To
evaluate the rhodamine delivery by NGs in vitro the nanodevices
were incubated for 24 h with microglial cells. At this time of
analysis, microglia showed clusterized NGs in the cytosol with
a colocalized Cy5 and RhB signals (Fig. 11Ac). Aer 4 days of
incubation, a markedly diﬀused signal of RhB was revealed in
the cytosol of the microglial cells and it was only partially
colocalized with Cy5 (Fig. 11Ad and e).
This quantitatively evaluated by Pearson's correlation index,
where rhodamine signal was more widespread diﬀused within
the cytosol, compared to Cy5-positive NGs (Fig. 11B). Further-
more, we evaluated the biocompatibility of internalized NGs in
microglial cell colture by MTS assay. Nanogel internalization
did not aﬀect microglia cell viability up to 4 days compared to
microglia not exposed to the polymeric systems (Fig. 11C). To
understand whether internalized NGs aﬀected the integrity of
cellular membranes we measured the level of lactate dehydro-
genase (LDH) released (Fig. S7†) in the culture medium. No
detectable amount of LDH release was revealed underlining the
biocompatibility of this colloidal system.
Conclusions
In this work, we investigated the possibility to carry hydrophilic
molecules within nanogels towards specic target and without
losing the drugs content in body uids. Indeed, the nanogel
traceability was successfully performed through a one-step
CuAAC click chemistry involving PEI and Cy5 dye. Then, to
improve drug delivery performances, we introduced a sensitive
cleavable bond (disulde) between polymeric chains and drug
molecules in order to create a selective drug delivery vehicle.
NGs were internalized by microglia, without detectable toxic
eﬀect. In vitro studies showed a selective drug release within the
cell cytosol of activated microglia conrming the eﬃcacy of this
tool. The incorporation of these types of linkers reduced the
drug escape to the surrounding environment compared to
systems where solute's release is only driven by a pure Fickian
diﬀusion mechanism. In conclusion, the approach proposed in
this work is a potential system to provide benet in diﬀerent
human neurologic pathologies opening new perspectives to the
inammatory treatment in the central nervous system, through
the modulated drug uptake and release of activated microglia.
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